Radiopharmaceuticals-Nuclear Medicine Market Strategic Plan for Positive Growth 2025 - Bayer, Bracco Imaging
Radiopharmaceuticals/nuclear medicine market report gives comprehensive outlook on radiopharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on radiopharmaceuticals/nuclear medicine market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application area, route of administration, end user, and geographic regions. Global radiopharmaceuticals market estimated to be valued US$ 5,146 Mn in 2018 and poised to grow at CAGR of 8.9% over 2019-2025. Market for radiopharmaceuticals projected to reach US$ 8,564 Mn by 2025 owing to increasing adoption in radio therapeutic and diagnostic procedures across the globe. Major Key Players of the Radiopharmaceuticals-Nuclear Medicine Market are: Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co...